The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX

134Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Patients with hemophilia have an impaired thrombin generation and therefore form loose fibrin hemostatic plugs that are easily dissolved by fibrinolysis. This prevents maintained hemostasis in these patients, resulting in a severe bleeding disorder. Recombinant (F)VIIa has been shown to enhance thrombin generation on already thrombin-activated platelets in the absence of FVIII and FIX. An efficacy rate of 80-90% has been found in hemophilia patients with inhibitors against FVIII or FIX both in association with major surgery and in the treatment of serious bleedings. In a model measuring fibrin clot permeability in a platelet-containing system described by Blombäck et al. (1994) this was demonstrated to be dependent on the concentration of FVIII and FIX. The addition of rFVIIa in concentrations of 1.9, 4.8 and 9.6 μgmL -1 normalized fibrin clot permeability. The concentration of 1.9 μgmL -1 of rFVIIa normalized clot permeability in this system and the higher concentrations of rFVIIa added only slightly to the effect. No further decrease in clot permeability was found when rFVIIa in a concentration of 1.9 μgmL -1 was added to a sample with a normal concentration (100%) of FVIII or FIX. Higher concentrations of rFVIIa added to the plasma containing 100% of FVIII or FIX induced only a slight further decrease of fibrin permeability constant, arguing against any unwanted effect of extra rFVIIa on clot permeability in the case of a normal hemostasis. Furthermore, the fibrin network was studied with 3D microscopy and the loose network found in the absence of FVIII or FIX increased in density with increasing FVIII or FIX concentrations. The addition of rFVIIa to FVIII- or FIX-deficient systems altered the network structure, making the fibers thinner and more tightly packed. © 2003 International Society on Thrombosis and Haemostasis.

References Powered by Scopus

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

674Citations
N/AReaders
Get full text

Platelet activity of high-dose factor VIIa is independent of tissue factor

537Citations
N/AReaders
Get full text

Treatment of traumatic bleeding with recombinant factor VIIa

424Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Recombinant activated factor VII for acute intracerebral hemorrhage

1203Citations
N/AReaders
Get full text

Thrombin generation and fibrin clot structure

621Citations
N/AReaders
Get full text

Fibrinogen and Fibrin in Hemostasis and Thrombosis

328Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

He, S., Blombäck, M., Jacobsson Ekman, G., & Hedner, U. (2003). The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. Journal of Thrombosis and Haemostasis, 1(6), 1215–1219. https://doi.org/10.1046/j.1538-7836.2003.00242.x

Readers over time

‘11‘14‘15‘16‘17‘18‘19‘20‘21‘22‘2302468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

38%

Researcher 11

38%

Professor / Associate Prof. 7

24%

Readers' Discipline

Tooltip

Medicine and Dentistry 15

63%

Biochemistry, Genetics and Molecular Bi... 5

21%

Agricultural and Biological Sciences 3

13%

Chemical Engineering 1

4%

Save time finding and organizing research with Mendeley

Sign up for free
0